Stay updated on SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page.

Latest updates to the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal regarding the study of SAGE-547 for super-refractory status epilepticus, including detailed descriptions of the study's purpose, methodology, and inclusion/exclusion criteria. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference7%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.5%
Stay in the know with updates to SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page.